Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.61B |
| 2 |
Microsoft
MSFT
|
+$1.17B |
| 3 |
Broadcom
AVGO
|
+$366M |
| 4 |
Merck
MRK
|
+$343M |
| 5 |
Meta Platforms (Facebook)
META
|
+$260M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$609M |
| 2 |
CMA
Comerica
CMA
|
+$512M |
| 3 |
CADE
Cadence Bank
CADE
|
+$422M |
| 4 |
Johnson & Johnson
JNJ
|
+$331M |
| 5 |
Western Digital
WDC
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.81% |
| 2 | Financials | 17.07% |
| 3 | Industrials | 12.54% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Healthcare | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Caledonia Mining Corp
CMCL
$361M
| $12.3M | ﹤0.01% |
544,657
+86,575
| +19% | +$2.41M |
|
2177
Thomson Reuters
TRI
$45.1B
| $12.3M | ﹤0.01% |
134,262
-82,812
| -38% | -$8.73M |
|
2178
Utah Medical Products
UTMD
$226M
| $12.3M | ﹤0.01% |
197,908
+1,399
| +0.7% | +$88.1K |
|
2179
Fortrea Holdings
FTRE
$1.96B
| $12.2M | ﹤0.01% |
1,299,862
+807,081
| +164% | +$10.4M |
|
2180
Vanda Pharmaceuticals
VNDA
$310M
| $12.2M | ﹤0.01% |
1,771,593
-346,835
| -16% | -$2.67M |
|
2181
Weyerhaeuser
WY
$17.7B
| $12.2M | ﹤0.01% |
499,922
+33,503
| +7% | +$843K |
|
2182
Core Scientific
CORZ
$6.6B
| $12.2M | ﹤0.01% |
814,454
-127,070
| -13% | -$2.17M |
|
2183
NLI Holdings
NL
$291M
| $12.2M | ﹤0.01% |
2,089,167
+15,950
| +0.8% | +$96.2K |
|
2184
Five Star Bancorp
FSBC
$1.02B
| $12.1M | ﹤0.01% |
321,938
+34,396
| +12% | +$1.32M |
|
2185
MannKind Corp
MNKD
$1.21B
| $12.1M | ﹤0.01% |
4,953,295
+509,692
| +11% | +$2.27M |
|
2186
Consumer Portfolio Services
CPSS
$207M
| $12.1M | ﹤0.01% |
1,565,930
-2,970
| -0.2% | -$24.8K |
|
2187
Inspire Medical Systems
INSP
$1.5B
| $12.1M | ﹤0.01% |
234,670
-106,727
| -31% | -$7.47M |
|
2188
Nurix Therapeutics
NRIX
$2.51B
| $12.1M | ﹤0.01% |
780,696
+349,710
| +81% | +$5.8M |
|
2189
Kodiak Sciences
KOD
$2.52B
| $12M | ﹤0.01% |
315,400
-12,082
| -4% | -$312K |
|
2190
Investar Holding Corp
ISTR
$415M
| $11.9M | ﹤0.01% |
437,405
+26,842
| +7% | +$751K |
|
2191
Bloomin' Brands
BLMN
$736M
| $11.9M | ﹤0.01% |
2,208,122
+1,013,953
| +85% | +$6.49M |
|
2192
Luxfer Holdings
LXFR
$456M
| $11.9M | ﹤0.01% |
976,873
+58,197
| +6% | +$810K |
|
2193
LendingTree
TREE
$572M
| $11.9M | ﹤0.01% |
277,414
+22,857
| +9% | +$1.09M |
|
|
KEEL
2194
Keel Infrastructure Corp
KEEL
$2.25B
| $11.9M | ﹤0.01% |
6,097,454
+2,940,978
| +93% | +$6.91M |
|
2195
Alico
ALCO
$284M
| $11.8M | ﹤0.01% |
287,141
-32,976
| -10% | -$1.31M |
|
2196
Designer Brands
DBI
$322M
| $11.8M | ﹤0.01% |
2,077,609
+269,795
| +15% | +$1.81M |
|
|
LTM
2197
LATAM Airlines Group S.A.
LTM
$15.4B
| $11.7M | ﹤0.01% |
237,965
+9,448
| +4% | +$534K |
|
2198
Flotek Industries
FTK
$856M
| $11.7M | ﹤0.01% |
691,593
+288,064
| +71% | +$4.95M |
|
2199
Stratus Properties
STRS
$156M
| $11.7M | ﹤0.01% |
384,228
-24,457
| -6% | -$708K |
|
2200
Cytek Biosciences
CTKB
$576M
| $11.6M | ﹤0.01% |
2,663,329
+16,438
| +0.6% | +$77.6K |
|
Similar funds
Dimensional Fund Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Dimensional Fund Advisors held 3,312 positions worth $481B, up 0.98% from $477B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q1 2026 filing shows 72 new, 1,935 increased, 1,135 reduced and 97 closed positions. Its largest new stake was Versant Media Group: 1,127,961 shares worth $41.7M. The largest sale was AstraZeneca, an estimated $609M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2026 buy was Versant Media Group: 1,127,961 shares worth $41.7M.
- Dimensional Fund Advisors added most to Amazon in Q1 2026, an estimated $1.61B increase.
- Dimensional Fund Advisors's biggest Q1 2026 reduction was Johnson & Johnson, cutting an estimated $331M.
- Dimensional Fund Advisors fully exited AstraZeneca in Q1 2026, selling an estimated $609M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $481B portfolio in Q1 2026.
- Dimensional Fund Advisors opened 72 new positions and closed 97 in Q1 2026.
- Dimensional Fund Advisors's portfolio value rose 0.98% quarter-over-quarter to $481B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.